Cancer Research Landon Prizes for Basic and Translational Cancer Research AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perletti, G.
Right arrow Articles by Chen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perletti, G.
Right arrow Articles by Chen, L.
[Cancer Research 60, 1793-1796, April 1, 2000]
© 2000 American Association for Cancer Research

Advances in Brief

Antitumor Activity of Endostatin against Carcinogen-induced Rat Primary Mammary Tumors1

Gianpaolo Perletti, Paola Concari, Roberto Giardini, Emanuela Marras, Francesco Piccinini, Judah Folkman2 and Longchuan Chen

Dipartimento di Biologia Strutturale e Funzionale, Università degli Studi dell’Insubria, 21100 Varese, Italy [G. P., P. C., E. M., F. P.]; Divisione di Anatomia Patologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, 20133 Milano, Italy [R. G.]; Department of Surgery, Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115 [J. F., L. C.]

Endostatin, a Mr 20,000 fragment of collagen XVIII, potently inhibits the growth of experimental tumors implanted in mice. Here we report the cloning, expression, and antitumor activity of the rat form of endostatin. When tested on breast carcinomas arising in female virgin rats after intragastric administration of 9,10-dimethyl-1,2-benzanthracene (DMBA), endostatin induced significant inhibition of mammary tumor growth in all of the treated rats during a 4-week treatment period without signs of systemic toxicity. Interestingly, this arrest of tumor growth persisted throughout a four-week off-therapy period. Moreover, endostatin was effective in counteracting the development of multiple primary tumors. These results confirm that rat endostatin is a potent anticancer agent in a carcinogen-induced, spontaneously arising rat breast cancer model. It not only stops the growth of existing tumors but also decreases the incidence of the development of multiple neoplastic lesions.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
G. Brideau, M. J. Makinen, H. Elamaa, H. Tu, G. Nilsson, K. Alitalo, T. Pihlajaniemi, and R. Heljasvaara
Endostatin Overexpression Inhibits Lymphangiogenesis and Lymph Node Metastasis in Mice
Cancer Res., December 15, 2007; 67(24): 11528 - 11535.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. H. Kulke, E. K. Bergsland, D. P. Ryan, P. C. Enzinger, T. J. Lynch, A. X. Zhu, J. A. Meyerhardt, J. V. Heymach, W. E. Fogler, C. Sidor, et al.
Phase II Study of Recombinant Human Endostatin in Patients With Advanced Neuroendocrine Tumors
J. Clin. Oncol., August 1, 2006; 24(22): 3555 - 3561.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Kirsch, P. Weigel, T. Pinzer, R. S. Carroll, P. McL. Black, H.-K. Schackert, and G. Schackert
Therapy of Hematogenous Melanoma Brain Metastases with Endostatin
Clin. Cancer Res., February 1, 2005; 11(3): 1259 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ponnazhagan, G. Mahendra, S. Kumar, D. R. Shaw, C. R. Stockard, W. E. Grizzle, and S. Meleth
Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy: Long-Term Efficacy of a Vector Encoding Angiostatin and Endostatin over Vectors Encoding a Single Factor
Cancer Res., March 1, 2004; 64(5): 1781 - 1787.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
G. R. Macpherson, S. S.W. Ng, S. L. Forbes, G. Melillo, T. Karpova, J. McNally, T. P. Conrads, T. D. Veenstra, A. Martinez, F. Cuttitta, et al.
Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay
Mol. Cancer Ther., September 1, 2003; 2(9): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. D. Eubank, M. Galloway, C. M. Montague, W. J. Waldman, and C. B. Marsh
M-CSF Induces Vascular Endothelial Growth Factor Production and Angiogenic Activity From Human Monocytes
J. Immunol., September 1, 2003; 171(5): 2637 - 2643.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
A. Reijerkerk, L. O. Mosnier, O. Kranenburg, B. N. Bouma, P. Carmeliet, T. Drixler, J. C.M. Meijers, E. E. Voest, and M. F.B.G. Gebbink
Amyloid Endostatin Induces Endothelial Cell Detachment by Stimulation of the Plasminogen Activation System
Mol. Cancer Res., June 1, 2003; 1(8): 561 - 568.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. P. Thomas, R. Z. Arzoomanian, D. Alberti, R. Marnocha, F. Lee, A. Friedl, K. Tutsch, A. Dresen, P. Geiger, J. Pluda, et al.
Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors
J. Clin. Oncol., January 15, 2003; 21(2): 223 - 231.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Iughetti, O. Suzuki, P. H. C. Godoi, V. A. Ferreira Alves, A. L. Sertie, T. Zorick, F. Soares, A. Camargo, E. S. Moreira, C. di Loreto, et al.
A Polymorphism in Endostatin, an Angiogenesis Inhibitor, Predisposes for the Development of Prostatic Adenocarcinoma
Cancer Res., October 1, 2001; 61(20): 7375 - 7378.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. Kisker, C. M. Becker, D. Prox, M. Fannon, R. D'Amato, E. Flynn, W. E. Fogler, B. K. L. Sim, E. N. Allred, S. R. Pirie-Shepherd, et al.
Continuous Administration of Endostatin by Intraperitoneally Implanted Osmotic Pump Improves the Efficacy and Potency of Therapy in a Mouse Xenograft Tumor Model
Cancer Res., October 1, 2001; 61(20): 7669 - 7674.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Hata, R. Fujiwaki, K. Nakayama, and K. Miyazaki
Expression of the Endostatin Gene in Epithelial Ovarian Cancer
Clin. Cancer Res., August 1, 2001; 7(8): 2405 - 2409.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Yokoyama, J. E. Green, V. P. Sukhatme, and S. Ramakrishnan
Effect of Endostatin on Spontaneous Tumorigenesis of Mammary Adenocarcinomas in a Transgenic Mouse Model
Cancer Res., August 1, 2000; 60(16): 4362 - 4365.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.